China’s $93.78 Bn Drug Delivery Market – Forecasts from 2019 to 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “China
Drug Delivery Market – Forecasts from 2019 to 2024” report has
been added to ResearchAndMarkets.com’s offering.

The China drug delivery market is projected to grow at a CAGR of 9.65%
to reach US$ 93.788 billion by 2024, from US$ 53.971 billion in 2018.

The drug delivery market in China is poised to grow at a fast pace owing
to high growth of Pharma Industry here, a rapidly aging population and
prevalence of chronic diseases. Furthermore, growing healthcare
expenditures is augmenting the market growth during the forecast period.
In the end, growing innovations in drug delivery will provide an
opportunity for the growth of the China drug delivery market in the
forecast period and beyond.

This research study examines the current market trends related to the
demand, supply, and sales, in addition to the recent developments. Major
drivers, restraints, and opportunities have been covered to provide an
exhaustive picture of the market. The analysis presents in-depth
information regarding the development, trends, and industry policies and
regulations being implemented by the relevant agencies. Further, the
overall regulatory framework of the market has been exhaustively covered
to offer stakeholders a better understanding of the key factors
affecting the overall market environment.

Identification of key industry players in the industry and their revenue
contribution to the overall business or relevant segment aligned to the
study have been covered as a part of competitive intelligence.

Major industry players profiled as part of the report are AstraZeneca
group companies, West Pharmaceutical Services, Inc., Becton, Dickinson
and Company, Medtronic, and Boston Scientific Corporation.

Key Topics Covered:

1. Introduction

1.1. Market Overview

1.2. Market Definition

1.3. Scope Of The Study

1.4. Currency

1.5. Assumptions

1.6. Base, And Forecast Years Timeline

2. Research Methodology

2.1. Research Design

2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter’s Five Force Analysis

4.5.1. Bargaining Power Of Suppliers

4.5.2. Bargaining Power Of Buyers

4.5.3. Threat Of New Entrants

4.5.4. Threat Of Substitutes

4.5.5. Competitive Rivalry In The Industry

4.6. Life Cycle Analysis – Regional Snapshot

4.7. Market Attractiveness

5. China Drug Delivery Market By Application

5.1. Treatment Of Diseases

5.2. Research/Academic Purposes

6. China Drug Delivery Market By Route Of Administration

6.1. Oral

6.2. Nasal

6.3. Transdermal

6.4. Intravenous

7. Competitive Intelligence

7.1. Recent Deals And Investment

7.2. Competitive Benchmarking And Analysis

7.3. Strategies Of Key Players

8. Company Profiles

• AstraZeneca group companies
• West Pharmaceutical Services, Inc.
• Becton, Dickinson and Company
• Medtronic
• Boston Scientific Corporation

For more information about this report visit https://www.researchandmarkets.com/r/bm2i0e

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Delivery